Previous AngIV analogs, while showing promise in animal models of dementia, were hindered by poor metabolic stability indicated by a short half-life, and an inability to cross the BBB due to their peptide nature
"Our members also need to know what changes will trigger the need to reconsider their current acceptance criteria, for example, a change of active pharmaceutical ingredient supplier in the post-approval setting." The Parenteral Drug Association (PDA) also asked FDA to harmonize with other regulatory bodies
Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition
Marques, Natlia Nunes, Bruno Paulo Rodrigues Lustosa, Daniel Wagner Castro Lima Santos, Flvio Queiroz-Telles, Sybren de Hoog, Renata R
But before we can even think about whether they help, its important to understand what they areand what we dont yet know about them